Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13705-13717
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13705
Figure 9
Figure 9 Quantification of ribonuclease protection assay of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 mRNA expressions in lung, colon, and breast malignant tumors (T) and corresponding non-malignant tissue counterparts (C). Values of PFKFB-3 and PFKFB-4 mRNA expressions were normalized to 18S rRNA; n = 15-20, bP < 0.01 vs non-malignant tissues[30,33]. PFKFB: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.